← FDA DRUG APPROVALS

FDA ANDA · ANDA085691

TRIAMCINOLONE ACETONIDE

Sponsor: FOUGERA PHARMS

APPLICATION
ANDA085691
TYPE
ANDA
ORIGINAL APPROVAL
1978-03-09
LATEST ACTION
2004-08-23
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Prescription

Products

TRIAMCINOLONE ACETONIDEPrescription
TRIAMCINOLONE ACETONIDE 0.5% · OINTMENT · TOPICAL
TRIAMCINOLONE ACETONIDEPrescription
TRIAMCINOLONE ACETONIDE 0.1% · OINTMENT · TOPICAL
TRIAMCINOLONE ACETONIDEPrescription
TRIAMCINOLONE ACETONIDE 0.025% · OINTMENT · TOPICAL

Approval history

2004-08-23Labeling · Supplement 35AP
1996-03-07Manufacturing (CMC) · Supplement 33AP
1994-12-30Manufacturing (CMC) · Supplement 32AP
1988-05-20Manufacturing (CMC) · Supplement 31AP
1988-05-20Manufacturing (CMC) · Supplement 27AP
1988-03-25Labeling · Supplement 30AP
1987-07-31Manufacturing (CMC) · Supplement 29AP
1986-09-25Manufacturing (CMC) · Supplement 26AP
1983-05-04Manufacturing (CMC) · Supplement 24AP
1983-05-04Manufacturing (CMC) · Supplement 25AP
1982-10-28Manufacturing (CMC) · Supplement 23AP
1982-07-27Manufacturing (CMC) · Supplement 17AP
1982-07-27Manufacturing (CMC) · Supplement 11AP
1982-07-27Manufacturing (CMC) · Supplement 16AP
1982-07-27Manufacturing (CMC) · Supplement 10AP
1982-07-27Manufacturing (CMC) · Supplement 19AP
1978-03-09OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →